Kazu Shiomi

911 total citations
64 papers, 674 citations indexed

About

Kazu Shiomi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Kazu Shiomi has authored 64 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 10 papers in Surgery. Recurrent topics in Kazu Shiomi's work include Lung Cancer Diagnosis and Treatment (25 papers), Lung Cancer Treatments and Mutations (16 papers) and Occupational and environmental lung diseases (8 papers). Kazu Shiomi is often cited by papers focused on Lung Cancer Diagnosis and Treatment (25 papers), Lung Cancer Treatments and Mutations (16 papers) and Occupational and environmental lung diseases (8 papers). Kazu Shiomi collaborates with scholars based in Japan, Canada and United States. Kazu Shiomi's co-authors include Yukinori Sakao, Hideaki Miyamoto, Satoshi Sonobe, Yukitoshi Satoh, Masashi Mikubo, Hiroshi Izumi, Masahito Naito, Okio Hino, Motoki Sakuraba and Masahiro Maeda and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kazu Shiomi

57 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazu Shiomi Japan 14 507 144 94 81 78 64 674
B. Castagneto Italy 15 567 1.1× 145 1.0× 58 0.6× 71 0.9× 44 0.6× 33 735
Paul Morris United States 10 386 0.8× 93 0.6× 84 0.9× 50 0.6× 112 1.4× 21 627
Yoshihiro Nakagami Japan 14 209 0.4× 148 1.0× 229 2.4× 73 0.9× 80 1.0× 51 583
Yuan Tian China 14 328 0.6× 217 1.5× 214 2.3× 29 0.4× 78 1.0× 67 644
Naoki Nishiyama Japan 11 241 0.5× 67 0.5× 198 2.1× 61 0.8× 133 1.7× 34 525
José Manuel Aramendía Spain 14 275 0.5× 326 2.3× 104 1.1× 46 0.6× 45 0.6× 46 587
Sudhir Isharwal United States 15 413 0.8× 103 0.7× 123 1.3× 80 1.0× 214 2.7× 37 567
Peigang Yang China 14 313 0.6× 202 1.4× 210 2.2× 28 0.3× 105 1.3× 58 650
Wan-Yi Kang Taiwan 11 247 0.5× 104 0.7× 150 1.6× 81 1.0× 100 1.3× 19 513
Fulya Öz Puyan Türkiye 14 109 0.2× 87 0.6× 128 1.4× 37 0.5× 158 2.0× 70 567

Countries citing papers authored by Kazu Shiomi

Since Specialization
Citations

This map shows the geographic impact of Kazu Shiomi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazu Shiomi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazu Shiomi more than expected).

Fields of papers citing papers by Kazu Shiomi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazu Shiomi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazu Shiomi. The network helps show where Kazu Shiomi may publish in the future.

Co-authorship network of co-authors of Kazu Shiomi

This figure shows the co-authorship network connecting the top 25 collaborators of Kazu Shiomi. A scholar is included among the top collaborators of Kazu Shiomi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazu Shiomi. Kazu Shiomi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Naito, Masahito, et al.. (2025). Characteristics of Oligo-Recurrence and Treatment Selection in Non-Small Cell Lung Cancer. Cancers. 17(14). 2293–2293.
2.
Naito, Masahito, et al.. (2025). Clinical Course After Radical Local Therapy for Oligo‐Recurrence of Nonsmall Cell Lung Cancer. Journal of Surgical Oncology. 131(8). 1551–1561. 1 indexed citations
3.
Shiomi, Kazu, Masaaki Ichinoe, Ryo Nagashio, et al.. (2025). Insight Into the Significance of CD8+ Tumor‐Infiltrating Lymphocytes in Lung Adenocarcinoma. Thoracic Cancer. 16(14). e70135–e70135. 1 indexed citations
4.
Naito, Masahito, et al.. (2024). Prognostic factors after radical local therapy for oligo-recurrence of non-small cell lung cancer. General Thoracic and Cardiovascular Surgery. 73(5). 352–361. 2 indexed citations
5.
Mikubo, Masashi, Masaaki Ichinoe, Masahito Naito, et al.. (2024). Radiologic Parameters Predicting the Histologic Invasiveness of Pure Ground-Glass Nodules. SHILAP Revista de lepidopterología. 2(3). 464–468.
6.
Naito, Masahito, et al.. (2023). Examination of the effectiveness of local therapy for oligo‐recurrence of EGFR‐mutated NSCLC. Thoracic Cancer. 14(8). 766–772. 7 indexed citations
7.
Mikubo, Masashi, Yukitoshi Satoh, Masahito Naito, et al.. (2023). Prognostic implications of prostaglandin E-major urinary metabolite in resected non-small-cell lung cancer. Interdisciplinary CardioVascular and Thoracic Surgery. 36(1). 1 indexed citations
8.
Naito, Masahito, et al.. (2023). Prognosis of patients with recurrent nonsmall cell lung cancer who received the best supportive care alone. Current Problems in Surgery. 61(1). 101429–101429. 5 indexed citations
10.
Naito, Masahito, et al.. (2021). Selection of preoperative stress electrocardiography test for appropriate patients with non-small cell lung cancer. General Thoracic and Cardiovascular Surgery. 70(2). 139–143. 1 indexed citations
11.
Naito, Masahito, et al.. (2021). Factors associated with lymph node metastasis upstage after resection for patients with micropapillary lung adenocarcinoma. Thoracic Cancer. 13(1). 48–53. 3 indexed citations
12.
Matsui, Yoshio, et al.. (2019). Resection of intra-pulmonary endometriosis by video-assisted thoracoscopic surgery under pre-operative CT-guided marking synchronized with menstrual cycle. General Thoracic and Cardiovascular Surgery. 68(5). 549–553. 4 indexed citations
13.
Satoh, Yukitoshi, Yukiko Matsuo, Kazuya Yamashita, et al.. (2019). EGFR mutation genotyping and ALK status determination in liquid-based cytology samples of non-small cell lung cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 476(5). 753–762. 11 indexed citations
14.
Shiomi, Kazu, Keishi Yamashita, Sohei Ito, et al.. (2018). Pulmonary torsion after open esophagectomy for esophageal cancer: a case report and review. Journal of Thoracic Disease. 10(6). E462–E468. 3 indexed citations
15.
Matsuo, Yukiko, Kazu Shiomi, Masashi Mikubo, et al.. (2017). Molecular alterations in a new cell line (KU-Lu-MPPt3) established from a human lung adenocarcinoma with a micropapillary pattern. Journal of Cancer Research and Clinical Oncology. 144(1). 75–87. 4 indexed citations
16.
Mikubo, Masashi, et al.. (2017). Spontaneous non-traumatic mediastinal hematoma associated with oral anticoagulant therapy: A case report and literature review. International Journal of Surgery Case Reports. 39. 221–224. 7 indexed citations
17.
Naito, Masahito, et al.. (2014). Thoracoscopically removed thoracolithiasis: A report of 3 cases. The Journal of the Japanese Association for Chest Surgery. 28(6). 809–815. 1 indexed citations
18.
Naito, Masahito, et al.. (2014). A resected case of pulmonary sequestration (Pryce type I) complicated by primary lung cancer. The Journal of the Japanese Association for Chest Surgery. 28(5). 640–645.
19.
Ohashi, Rina, Ken Tajima, Ri Cui, et al.. (2009). Osteopontin Modulates Malignant Pleural Mesothelioma Cell Functions in Vitro. Haigan. 49(4). 368–375. 13 indexed citations
20.
Watanabe, Hirokazu, Hideo Kunitoh, Seiichiro Yamamoto, et al.. (2006). Effect of the introduction of minimum lesion size on interobserver reproducibility using RECIST guidelines in non‐small cell lung cancer patients. Cancer Science. 97(3). 214–218. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026